Terson Syndrome Before Induction Chemotherapy for Acute Lymphoblastic Leukemia
YunZu Michele Wang1, Eric Nudleman2, Daniel Vinocur3
1Departments of Pediatric Hematology-Oncology.
Journal of Pediatric Hematology/Oncology
|December 5, 2017
Summary
A 2-year-old presented with pancytopenia and acute lymphoblastic leukemia, later developing intracranial and vitreous hemorrhage. This case highlights Terson syndrome in a pediatric leukemia patient, a rare but serious complication.
Area of Science:
- Pediatric Hematology Oncology
- Neuro-Ophthalmology
Background:
- Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
- Intracranial hemorrhage (ICH) and intraocular hemorrhage (IOH) are serious complications.
- Terson syndrome links ICH with IOH, typically seen in adults.
Observation:
- A previously healthy 2-year-old female infant with pancytopenia was diagnosed with ALL.
- Prior to leukemia treatment, she exhibited symptoms of increased intracranial pressure.
- Head imaging confirmed left parietal hemorrhage and right vitreous hemorrhage.
Findings:
- The patient presented with both intracranial and intraocular hemorrhages.
- This presentation is consistent with Terson syndrome.
- Ocular manifestations in leukemia are uncommon at diagnosis and usually asymptomatic.
Implications:
- This case suggests Terson syndrome can occur in pediatric patients with acute lymphoblastic leukemia.
- Early recognition of neurological and ophthalmological symptoms is crucial in pediatric leukemia.
- Further research is needed to understand the incidence and management of Terson syndrome in pediatric leukemia.

![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
